Sanofi Gets Covid-19 Sales Burst as Lockdowns Fueled Stocking Up

(Bloomberg) -- Sanofi’s sales and profit rose in the first quarter as consumers snapped up the drugmaker’s treatments ahead of lockdowns -- a short-lived boon from the Covid-19 pandemic.